In image-guided radiotherapy (IGRT) of patients with pancreatic ductal adenocarcinoma (PDAC), implanted fiducial gold markers are used for position verification and for registration of computed tomography (CT) and MRI scans used for delineation purposes. Recently, a liquid biodegradable carbohydrate based injectable soft tissue marker, compatible with CT and MRI, has been developed. Our aim was to quantitatively evaluate the tradeoff between visibility and artifacts of this marker on MRI and compare this with two solid fiducial gold markers commonly used in IGRT of PDAC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords